v3 Template
T

The Mark Foundation for Cancer Research

Healthcare ~580 employees
Founded
--
Employees (Est.)
~580
29 leaders known
Total Funding
$4.0M
Funding Rounds
1
Last Funding
2026-02-10

About The Mark Foundation for Cancer Research

The Mark Foundation for Cancer Research is dedicated to accelerating revolutionary cancer research by funding innovative projects and supporting the next generation of oncology breakthroughs. Their mission focuses on advancing cancer treatment and early detection through grants and partnerships.

Products & Services

ASPIRE Award:Supports proof-of-concept projects for new ideas and technologies in cancer research.
Drug Discovery Award:Provides resources and partnerships for academic drug discovery in cancer treatment.
Emerging Leader Award:Supports rising star investigators in cancer research.
Endeavor Award:Funds teams of researchers for innovative global collaborations in cancer research.
Fellowships:Offers postdoctoral awards and co-sponsored fellowships for cancer research.
Mark Foundation Centers:Supports large, long-term collaborations to tackle major challenges in cancer research.
Early Detection Award:Focuses on research for early detection of cancers.

Specialties

Cancer Research Drug Discovery Early Detection Oncology Breakthroughs Team Science Collaborations

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 4000000
MR: -
FA: $4 million
FAN: 4000000
D: 2026-02-10
FD: 2026-02-10
6 investors
Grant Latest
2026-02-10
$4.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Raymond N. DuBois

Executive Chair, Board of Directors

A

Alex Knaster

Chairman and CEO

R

Ross Levine

Chief Scientific Officer

N

Nicola Mendelsohn CBE

Head of Global Business Group at Meta

P

Paul Pospisil

Senior Client Partner in Biotechnology & Pharmaceuticals

S

Samuel Waxman

Director of the Samuel Waxman Institute for Aging & Cancer

View 26 more team members with Pro

Unlock Full Team Directory

Recent News

The Mark Foundation for Cancer Research Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare
Company Size
~580 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro